These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25109879)

  • 1. The impact of testosterone, tibolone and black cohosh on purified mammary and placental 17β-hydroxysteroid dehydrogenase type 1.
    Stute P; Kalkhake K; Kiesel L; Götte M
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):448-57. PubMed ID: 25109879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
    Lundström E; Hirschberg AL; Söderqvist G
    Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17-beta-Hydroxysteroid dehydrogenase type 1: computational design of active site inhibitors targeted to the Rossmann fold.
    Brown WM; Metzger LE; Barlow JP; Hunsaker LA; Deck LM; Royer RE; Vander Jagt DL
    Chem Biol Interact; 2003 Feb; 143-144():481-91. PubMed ID: 12604234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of active human 17β-Hydroxysteroid dehydrogenase type 1 from Escherichia coli.
    Bekić SS; Plavša JJ; Pavšič M; Lenarčič B; Petri ET; Ćelić AS
    Acta Chim Slov; 2024 Apr; 71(2):256-263. PubMed ID: 38919102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
    Purohit A; Malini B; Hooymans C; Newman SP
    Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of phenyl substituted 1H-1,2,4-triazoles as non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 2.
    Al-Soud YA; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
    Arch Pharm (Weinheim); 2012 Aug; 345(8):610-21. PubMed ID: 22532378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells.
    Kruchten P; Werth R; Bey E; Oster A; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):200-6. PubMed ID: 19429452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
    Fink BE; Gavai AV; Tokarski JS; Goyal B; Misra R; Xiao HY; Kimball SD; Han WC; Norris D; Spires TE; You D; Gottardis MM; Lorenzi MV; Vite GD
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1532-6. PubMed ID: 16386902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-selectivity: the mechanism of action of tibolone.
    Kloosterboer HJ
    Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor.
    Verma MK; Miki Y; Abe K; Suzuki T; Niikawa H; Suzuki S; Kondo T; Sasano H
    J Transl Med; 2013 Jul; 11():167. PubMed ID: 23837683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore modelling of 17beta-HSD1 enzyme based on active inhibitors and enzyme structure.
    Karkola S; Alho-Richmond S; Wahala K
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):225-8. PubMed ID: 18822344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary evaluation of a modified estradiol-core bearing a fused γ-lactone as non-estrogenic inhibitor of 17β-hydroxysteroid dehydrogenase type 1.
    Ouellet E; Ayan D; Poirier D
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5510-3. PubMed ID: 21782424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
    Messinger J; Hirvelä L; Husen B; Kangas L; Koskimies P; Pentikäinen O; Saarenketo P; Thole H
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):192-8. PubMed ID: 16413669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the origins of 17β-hydroxysteroid dehydrogenase type 1 inhibitory activity via QSAR and molecular docking.
    Srungboonmee K; Songtawee N; Monnor T; Prachayasittikul V; Nantasenamat C
    Eur J Med Chem; 2015; 96():231-7. PubMed ID: 25884113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites.
    Raobaikady B; Day JM; Purohit A; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):229-37. PubMed ID: 15862970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase.
    Raobaikady B; Parsons MF; Reed MJ; Purohit A
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):154-60. PubMed ID: 17467267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of pyrazole and imidazole-dehydroepiandrosterone derivatives on the activity of 17β-hydroxysteroid dehydrogenase.
    Cabeza M; Posada A; Sánchez-Márquez A; Heuze Y; Moreno I; Soriano J; Garrido M; Cortés F; Bratoeff E
    J Enzyme Inhib Med Chem; 2016; 31(1):53-62. PubMed ID: 25690043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of fused 16β,17β-oxazinone-estradiol derivatives as a new family of non-estrogenic 17β-hydroxysteroid dehydrogenase type 1 inhibitors.
    Maltais R; Trottier A; Delhomme A; Barbeau X; Lagüe P; Poirier D
    Eur J Med Chem; 2015 Mar; 93():470-80. PubMed ID: 25728028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human type 2 17 beta-hydroxysteroid dehydrogenase mRNA and protein distribution in placental villi at mid and term pregnancy.
    Drolet R; Simard M; Plante J; Laberge P; Tremblay Y
    Reprod Biol Endocrinol; 2007 Jul; 5():30. PubMed ID: 17623101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.